Common Stock, Shares, Outstanding of Theravance Biopharma, Inc. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Theravance Biopharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • Theravance Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 50,672,000, a 3% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Theravance Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 50,672,000 +1,498,000 +3% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 50,361,000 +1,439,000 +2.9% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 50,001,000 +1,435,000 +3% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 49,471,000 +1,380,000 +2.9% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 49,174,000 -1,645,000 -3.2% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 48,922,000 -4,772,000 -8.9% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 48,566,000 -11,976,000 -20% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 48,091,000 -17,136,000 -26% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 50,819,000 -16,547,000 -25% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 53,694,000 -22,733,000 -30% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 60,542,000 -15,539,000 -20% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 65,227,000 -9,208,000 -12% 31 Dec 2022 10-K 01 Mar 2024 2023 FY
Q3 2022 67,366,000 -6,332,000 -8.6% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 76,427,000 +2,957,000 +4% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 76,081,000 +10,863,000 +17% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 74,435,000 +10,107,000 +16% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 73,698,000 +9,742,000 +15% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 73,470,000 +9,955,000 +16% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 65,218,000 +2,214,000 +3.5% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 64,328,000 +7,313,000 +13% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 63,956,000 +7,194,000 +13% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 63,515,000 +6,878,000 +12% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 63,004,000 +6,882,000 +12% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 57,015,000 +1,334,000 +2.4% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 56,762,000 +1,352,000 +2.4% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 56,637,000 +1,533,000 +2.8% 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 56,122,000 +1,324,000 +2.4% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 55,681,000 +1,300,000 +2.4% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 55,410,000 +1,323,000 +2.4% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 55,104,000 +1,275,000 +2.4% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 54,798,000 +1,508,000 +2.8% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 54,381,000 +1,548,000 +2.9% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 54,087,000 +5,995,000 +12% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 53,829,000 +5,976,000 +12% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 53,290,000 +11,838,000 +29% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 52,833,000 +14,852,000 +39% 31 Dec 2016 10-K 28 Feb 2018 2017 FY
Q3 2016 48,092,000 +14,157,000 +42% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 47,853,000 +13,914,000 +41% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 41,452,000 +7,650,000 +23% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 37,981,000 +5,760,000 +18% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 33,935,000 +1,707,000 +5.3% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 33,939,000 +1,679,000 +5.2% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 33,802,000 31 Mar 2015 10-Q 13 May 2015 2015 Q1
Q4 2014 32,221,000 +32,221,000 31 Dec 2014 10-K 11 Mar 2016 2015 FY
Q3 2014 32,228,000 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 32,260,000 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q4 2013 0 31 Dec 2013 10-K 13 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.